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ABSTRACT
Methicillin-resistant Staphylococcus aureus (MRSA) is the common name for a heterogeneous group
of highly drug-resistant staphylococci. Two major MRSA classes are distinguished based on
epidemiology, namely community-associated (CA) and hospital-associated (HA) MRSA. Notably, the
distinction of CA- and HA-MRSA based on molecular traits remains difﬁcult due to the high genomic
plasticity of S. aureus. Here we sought to pinpoint global distinguishing features of CA- and HA-
MRSA through a comparative genome and proteome analysis of the notorious MRSA lineage
USA300. We show for the ﬁrst time that CA- and HA-MRSA isolates can be distinguished by 2
distinct extracellular protein abundance clusters that are predictive not only for epidemiologic
behavior, but also for their growth and survival within epithelial cells. This ‘exoproteome proﬁling’
also groups more distantly related HA-MRSA isolates into the HA exoproteome cluster. Comparative
genome analysis suggests that these distinctive features of CA- and HA-MRSA isolates relate
predominantly to the accessory genome. Intriguingly, the identiﬁed exoproteome clusters differ in
the relative abundance of typical cytoplasmic proteins, suggesting that signatures of cytoplasmic
proteins in the exoproteome represent a new distinguishing feature of CA- and HA-MRSA. Our
comparative genome and proteome analysis focuses attention on potentially distinctive roles of
‘liberated’ cytoplasmic proteins in the epidemiology and intracellular survival of CA- and HA-MRSA
isolates. Such extracellular cytoplasmic proteins were recently invoked in staphylococcal virulence,








Staphylococcus aureus is a wide-spread commensal bac-
terium, but also a notoriously drug-resistant pathogen
that causes a wide range of diseases, varying from mild
skin infections to life-threatening invasive diseases.1
About 20–30% of the healthy human population is
known to carry S. aureus, the anterior nares being the
preferred niche.2
Since the clinical implementation of antibiotics, S.
aureus has acquired a range of resistance traits through
mutations and horizontal gene transfer. This has
culminated in the emergence of methicillin-resistant S.
aureus (MRSA), a major healthcare problem world-
wide.3,4 The emergence of MRSA is a particularly worri-
some development since it is associated with increased
morbidity and mortality, especially if very young,
immune-compromised or elderly individuals are
infected.5,6 Moreover, no effective vaccine against MRSA
is currently available.7-9
Two major classes of MRSA are currently distinguished
based on their epidemiology, namely community-associated
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(CA) and hospital-associated (HA) MRSA. CA-MRSA is
mainly a threat to healthy individuals, causing in particular
skin and soft tissues infections, but also serious invasive
infections such as pneumonia and osteomyelitis.10-13 In con-
trast, HA-MRSA infections are associated with prolonged
hospitalization, stay in intensive care units, hemodialysis,
surgery, and long-term exposure to antibiotics.14
Molecular markers for high-conﬁdence distinction
between CA- and HA-MRSA isolates are urgently
needed in the prevention and control of hospital
outbreaks. Different DNA typing methods, such as
pulsed-ﬁeld gel electrophoresis (PFGE) and Staphylococ-
cus protein A (spa) typing have been used to differentiate
between these 2 classes of MRSA.15 This was so far feasi-
ble, because particular S. aureus lineages with distinct
sequence types are associated with the CA- or HA-asso-
ciated behavior. In addition, particular virulence genes
(e.g. for the Panton-Valentin leukocidin; PVL), the argi-
nine catabolic mobile element (ACME), and mobile
genetic elements carrying the mecA gene for methicillin
resistance are used to distinguish CA- and HA-
MRSA.11-14,16,17 However, such DNA-based typing
methods do not allow easy distinction between closely
related CA- and HA-MRSA lineages, because the causa-
tive molecular features have remained largely enigmatic.
For instance, PFGE assigns CA-MRSA isolates with the
spa type t008 and HA-MRSA isolates with the spa type
t024 to the same USA300 lineage.18 Likewise, spa typing
has insufﬁcient discriminatory power to distinguish
closely related CA and HA isolates as it assigns CA-
USA300 isolates with the multi-locus sequence type ST8
and more distantly related HA isolates with the sequence
type ST8 to the same spa type t008.18 Nevertheless, we
have previously shown that a multiple-locus variable
number tandem repeat ﬁngerprinting (MLVF) approach
may distinguish these highly related S. aureus isolates.19
An important challenge for the clinic is that S. aureus
types previously regarded as CA, such as USA300 and
the European ST80 clone, are becoming common hospi-
tal pathogens causing outbreaks.18,20-22 Clearly, an
increasing prevalence of CA-MRSA in the community
makes it harder to exclude the respective lineages from
hospitals, because they can be carried into the hospitals
by MRSA-positive patients, healthcare workers and visi-
tors. Furthermore, it is conceivable that these bacteria
have acquired, either before or after entry into the hospi-
tal environment, properties that facilitate their spread in
this setting. The latter view would be supported by the
observation that the closely related USA300 isolates with
spa types t008 and t024 display different epidemiology.18
The distinction of CA- and HA-MRSA at the molecu-
lar level is challenging, because many factors may con-
tribute to bacterial epidemiological behavior, not in the
last place interactions with the human host. High-
throughput analytical ‘omics’ approaches, especially
genomics and proteomics, are particularly suitable for
exploring such multi-factorial behavior since they allow
the deﬁnition of feature- or condition-speciﬁc signa-
tures.23,24 Furthermore, proteomics applied to bacterial
pathogens grown under infection-mimicking conditions
is a powerful tool for investigating different lineage- or
type-speciﬁc patterns of gene expression.25 In the context
of infection-related research, it is important to focus spe-
cial attention on the extracellular proteome (‘exopro-
teome’) as it represents the main reservoir of virulence
factors that are ﬁrst in interacting with the human
host.26,27 Speciﬁcally, secreted toxins and other virulence
factors of S. aureus contribute to tissue damage, host
invasion, and evasion of the host’s immune
responses.28,29 Thus, proteomics has a high potential for
identifying diagnostic biomarkers, and novel vaccine or
drug targets.30
To obtain a better understanding of the molecular dif-
ferences between CA- and HA-MRSA, the present study
was aimed at a global comparative genome and exopro-
teome analysis of 12 MRSA isolates belonging to the
USA300 lineage as deﬁned by PFGE. As these isolates
were all collected from Denmark (DK), we refer to them
as the CADK and HADK isolates. Speciﬁcally, the CADK
group had the sequence type ST8, the spa type t008 and
was PVL-positive, whereas the HADK group was charac-
terized by the sequence type ST8 and the spa type
t024.18,21 As a control group, we also investigated the
exoproteomes of 3 HA-MRSA isolates from the Dutch
(NL) - German (DE) border region, here referred to as
HANL-DE, which have the sequence type ST8, and spa
type t008 or t024.19 The genomes of all 15 isolates were
sequenced, and their extracellular proteins were analyzed
by liquid chromatography and mass spectrometry (LC-
MS). In brief, CA and HA isolates could be distinguished
to some extent by the accessory genome. More impor-
tantly, a principal component analysis (PCA) of the exo-
proteome MS data clustered the 15 investigated isolates




Whole genome sequence analysis was performed to
determine the genomic similarities and differences of all
15 investigated isolates. A phylogenetic tree based on the
core genome of the isolates showed that the 6 CADK, and
5 of the 6 HADK isolates formed 2 distinct clusters
(Fig. 1). One HADK isolate (D3) showed a more distant
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relationship with the other HADK isolates. Furthermore,
the 3 HANL-DE isolates formed a separate cluster that is
closer to the CADK than the HADK isolates. In addition
to the phylogenetic analysis, a comparative analysis of
the accessory genomes of the isolates was performed,
which is presented as a heatmap in Fig. 1. As illustrated
in the heat map, the CA isolates have overall more acces-
sory genes than the HA isolates. Perhaps more impor-
tantly, the clustering of accessory genes is indicative of a
separation between the CA and HA isolates, irrespective
of the geographical origin of the HA isolates. This sepa-
ration is also reﬂected in the presence or absence of sev-
eral known virulence genes (red lines in Fig. 1), such as
the PVL-encoding genes lukF and lukS that were
exclusively found in the CA isolates, and the entero-
toxin-encoding genes sea, sed, sej, and ser that were only
present in the investigated HA isolates (Table S1). Of
note, PVL is often used as a marker for CA-MRSA and
enterotoxin genes appear to be rare in CA isolates of the
USA300 lineage,31 but a possible association of entero-
toxin genes with HA behavior would be novel.
Both CA- and HA-MRSA isolates carried a norA gene
that provides resistance to ﬂuoroquinolones, and mecA
and blaZ genes for b-lactam resistance (Table S2). Genes
potentially providing resistance to macrolides, lincosa-
mides and streptogramin B (msr(A)), aminoglycosides
(aph(30)-III), and macrolides (mph(C)) were exclusively
identiﬁed in the CA-MRSA isolates, whereas erm(A) and
spc that provide resistance to macrolides and
aminoglycosides, respectively, were exclusively identiﬁed
among the HA-MRSA isolates (Table S2). Altogether, the
CA-MRSA isolates carried more (potential) antimicrobial
resistance genes than the investigated HA-MRSA isolates.
Unique and shared exoproteins
To characterize the exoproteomes of the 15 MRSA iso-
lates, they were cultured in RPMI medium since a recent
study showed that global gene expression proﬁles of S.
aureus cells grown in RPMI or human plasma are highly
similar.24 Samples were withdrawn for exoproteome anal-
yses at mid-exponential growth phase and 90 min after
entry into the stationary phase. No major differences in
the growth curves of the 15 MRSA were observed (data
not shown). As shown by gel-free mass spectrometry, a
total number of 409 unique proteins was identiﬁed from
the 15 exoproteome samples of exponentially grown iso-
lates. Similarly, a total number of 458 unique proteins was
identiﬁed from the 15 exoproteome samples generated
from stationary phase cultures. Proteins were considered
for further analyses when they were present in at least
50% of the isolates of a particular group, i.e. when a pro-
tein was present in 3 out of the 6 isolates in CADK and
HADK, and in 2 out of 3 isolates in HANL-DE. Thus, 283
and 307 unique proteins identiﬁed in the exponential or
stationary phase samples, respectively, were included in
the subsequent analyses (Table S3). The majority of these
proteins was shared by all 3 groups both in the
Figure 1. Phylogenetic tree and accessory genomes of all 15 investigated CADK, HADK and HANL-DE isolates. The tree is midpoint rooted
and bootstrap support >70% is indicated on the branches. The heatmap to the right of the phylogenetic tree illustrates the accessory
genome. The columns of the heatmap are hierarchically clustered based on the presence/absence of genes. Known virulence genes are
indicated in red. Examples of virulence genes that are exclusively present in one of the 3 groups are indicated as group-speciﬁc viru-
lence genes.
VIRULENCE 893
exponential (Fig. 2a) and stationary (Fig. 2b) growth
phases. Importantly, there are more proteins shared by
the HADK and HANL-DE isolates than by the HADK or
HANL-DE isolates and CADK isolates. This implies that, in
terms of exoprotein production, the 2 groups of HA iso-
lates are more closely related with each other than the HA
and CA isolates. Furthermore, unique proteins ranging
from 2 to 12 proteins in the exponential growth phase,
and 3 to 10 proteins from the stationary growth phase,
which were speciﬁc to only one of the 3 groups of isolates
were identiﬁed (Fig. 2a, b). Together, these data show that
the majority of extracellular proteins of the CADK, HADK
and HANL-DE is common. Yet, a subset of the exoproteins
appears to be speciﬁc for each of the 3 groups of isolates.
Predicted sub-cellular localization of identiﬁed
exoproteins
Bacterial exoproteomes are known to contain proteins
that are actively secreted and proteins that are liberated
from the cells through (auto-)lysis or other unidentiﬁed
‘non-classical secretion’ mechanisms.27,32-37 These pro-
teins can be distinguished through signal peptide predic-
tions, which is relevant as most known virulence factors
contain signal peptides to direct their export from the
cytoplasm.26 Thus, we predicted the sub-cellular localiza-
tion of proteins that were identiﬁed by MS. The vast
majority of the proteins identiﬁed in the exoproteomes
of the isolates in the exponential and stationary growth
phases were assigned to the class of cytoplasmic proteins
followed by secreted proteins, lipoproteins, cytoplasmic
membrane proteins and cell wall-associated proteins
(Fig. 3a, b). Notably, in the exponential growth phase,
the numbers of accessory exoproteins that were
predicted as cytoplasmic were higher in the CADK group
than in the HADK and HANL-DE groups (Fig. 3c). Con-
versely, in the stationary phase, the numbers of accessory
exoproteins predicted as cytoplasmic were higher among
the HADK and HANL-DE groups than in the CADK group
(Fig. 3d). For exoproteins with a predicted localization in
the membrane (i.e., membrane- and lipoproteins) or cell
wall no major differences were observed in the 3 groups,
irrespective of the growth phase (data not shown). Lastly,
higher numbers of predicted secretory proteins were
identiﬁed in growth media of the HA group than the CA
group in both growth phases. Altogether, these data
imply that the investigated CA and HA isolates are simi-
lar in terms of the predicted localization of their exopro-
teins. Nonetheless, the main distinction among these
groups was the time point at which cytoplasmic proteins
are liberated from the cells.
Relative extracellular abundance of known
and putative virulence factors
To obtain more comprehensive insights in the possible dif-
ferences in the levels of known extracellular virulence fac-
tors, we assessed their relative abundance for the different
investigated isolates.Detailed evaluation of the normalized
spectral counts showed differential and similar expression
levels for 24 virulence factors among the 3 groups of iso-
lates both in the exponential growth phase (Fig. 4a), and in
the stationary growth phase (Fig. 4b). Of note, neither PVL
nor enterotoxins that were identiﬁed as potentially distin-
guishing features for CA and HA isolates based on the
genome sequence were detectable in the extracellular pro-
teome. On the other hand, statistically signiﬁcantly differ-
ent levels of the IsdA, IsdB, SCIN and Vwb proteins were
Figure 2. Shared and uniquely identiﬁed proteins in CADK, HADK and HANL-DE S. aureus isolates. The Venn diagrams relate to cells in the
exponential (a) and stationary (b) growth phases. The numbers of commonly and uniquely identiﬁed proteins of the different groups of
isolates are indicated.
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identiﬁed in the growth media of exponentially growing
isolates, and the same was true for the Ebps, IsdB, SCIN
and Vwb proteins in the growth media of stationary grow-
ing isolates (Fig. 4a, b, Table S4).
The relative amounts of individual secreted exoproteins
are likely important for the behavior of the respective S.
aureus isolate, especially where this concerns secreted tox-
ins or immune evasion factors. Therefore, we determined
the relative abundance of proteins in the 3 groups of iso-
lates from the normalized spectral counts of proteins. A
volcano plot was used to present the proteins that were
detectable at statistically signiﬁcantly higher or lower levels
among the 3 groups of isolates during both the exponential
and stationary growth phases. From the total of 283 pro-
teins identiﬁed in samples collected in the exponential
growth phase, a relatively large number of proteins was
present at statistically signiﬁcantly different levels when
the CADK and the 2 HA isolate groups (i.e HADK and
HANL-DE) were compared, and this difference was larger
than the difference between the HADK and HANL-DE iso-
lates (Fig. 5a; Table S2). A similar pattern was observed for
the samples harvested during the stationary phase
(Fig. 5b). Additionally, some proteins were exclusively
present in one group of isolates, e.g., the chemotaxis inhibi-
tory protein (CHIPS) was identiﬁed only in CADK, the
enterotoxin type D only in HADK, and the enterotoxin type
A only in HANLDE isolates, and this applied both to expo-
nential and stationary phase growth medium samples
(Table S5). Together, these data show differences in the rel-
ative abundance of extracellular proteins at statistically sig-
niﬁcant levels in all the 3 groups of isolates, but especially
for the CA andHA isolates.
Levels of mRNA for selected exoproteins
The abundance of a bacterial exoprotein reﬂects the net
result of transcription of the respective gene, mRNA
translation, translocation of the precursor protein across
the membrane, post-translocational folding of the pro-
tein into a stable conformation, cell wall passage and the
protein’s stability in the bacterial extracellular milieu.
This implies that extracellular protein abundance is not
Figure 3. Predicted subcellular localization of identiﬁed extracellular proteins. The predicted subcellular localization of all 494 identiﬁed
extracellular proteins is shown for cells in the exponential (a) and stationary (b) growth phases. Panels (c) and (d), respectively, highlight
the appearance of predicted cytoplasmic core and accessory cytoplasmic proteins in the growth medium of the CADK, HADK and HANL-DE
isolates in the exponential and stationary growth phases. The numbers of proteins identiﬁed in each category are indicated at the top
of the bars.
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always linearly correlated with the transcript levels. Yet,
mRNA levels are major determinants for protein expres-
sion levels. Therefore, a Northern blotting analysis was
performed to assess whether there is a possible correla-
tion between transcript levels and extracellular protein
abundance. Speciﬁcally, we compared the transcript lev-
els for a secreted virulence factor (ebpS) and 2 cytosolic
proteins (fabF and rpoB). Consistent with the MS data,
in the stationary phase, the mRNA level of ebpS was
higher in HA isolates than in the CA isolates (Fig. 6a),
whereas the mRNA levels of fabF and rpoB were higher
in the CA isolates compared with the HA isolates
(Fig. 6b, c). Of note, the fabF and rpoB mRNA levels in
the CADK isolate D29 were more similar to the respective
mRNA levels in HADK isolates than to those in the CADK
isolates. On the other hand, 2 of HADK isolates (D30 and
D66), displayed fabF and rpoB mRNA levels comparable
to those observed for the CADK isolates.
Northern blotting analyses can also provide infor-
mation on the expression of genes for which the
encoded proteins were not covered by the proteome
analysis. Since phenol-soluble modulins (PSMs) are
particularly relevant for virulence, but notoriously dif-
ﬁcult to identify by proteomics due to their small size,
we investigated the psma1–4 mRNA levels by North-
ern blotting. In the stationary growth phase, the
psma1–4 mRNA levels were higher in most of the
HADK isolates than in the CADK isolates (Fig. 6d).
However, also the CADK isolate D29 showed a rela-
tively high level of psma1–4 mRNA that was compara-
ble to the psma1–4 mRNA levels in the HADK isolates
(Fig. 6d). Based on these Northern blotting data, the
proteomics data were reassessed with less stringent cri-
teria where we considered also proteins identiﬁed with
only one peptide. Thus, we were able to identify both
the PSMb1 and PSMb2 proteins in medium fractions
of 5 out of the 6 HADK isolates grown to stationary
phase. Of note, the same was true for the D29 CADK
isolate. These ﬁndings are fully consistent with the rel-
ative mRNA levels detected by Northern blotting.
Figure 4. Heat map analysis of quantiﬁed extracellular virulence factors. The normalized spectral counts of known extracellular virulence
factors identiﬁed by Mass Spectrometry in growth media of the 3 groups of isolates are graphically represented as colored heat maps.
Each heat map includes 3 columns representing each of the 3 groups of the isolates. Of note, each column of CADK and HADK isolates is
based on the average of 6 different isolates each analyzed in duplicate, and the HANL-DE column is based on the average of 3 different iso-
lates each analyzed in duplicate. Each row represents a particular protein. Panels (a) and (b) represent known virulence factors of S. aureus
as identiﬁed in the growth medium fractions of cells in the exponential and stationary growth phases, respectively. Statistically signiﬁcant
differences in relative abundance of the proteins marked between the groups; # Proteins present in one group of isolates only.
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Clustering of CA and HA isolates based on
exoproteome abundance signatures
Principal component analysis (PCA) was performed to
assess the overall relationships between the different
investigated isolates in terms of their exoproteome pro-
ﬁles. Of note, this PCA was based on the normalized
spectral counts of proteins that were produced by all 3
groups of isolates, speciﬁcally 283 proteins from expo-
nentially growing bacteria, and 308 proteins from bacte-
ria in the stationary growth phase. Importantly, the PCA
analysis revealed that the CA- and HA-MRSA isolates
clustered in 2 distinct groups based on the ‘exoprotein
abundance signatures’ where the HA cluster included
Figure 5. Differences in relative extracellular protein abundance in CADK, HADK and HANL-DE isolates. Statistically signiﬁcant differences in
the relative abundance of identiﬁed extracellular proteins are presented in volcano plots for samples collected in the exponential (a) and
stationary (b) growth phases. Horizontal blue lines indicate a p-value threshold of 0.05.
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both the HANL-DE and the HADK isolates (Fig. 7a, b) irre-
spective of their geographical origin. Yet, the HA cluster
included 2 CADK isolates (D29 and D61), whose exopro-
tein abundance signatures apparently resemble those of
the analyzed HA isolates.
The PCA analysis in Fig. 7 was based on all identiﬁed
extracellular proteins, including proteins with different
predicted subcellular localizations. To assess whether the
discriminating information relates to proteins with a par-
ticular predicted localization site, PCA analysis was per-
formed on: i, predicted cytoplasmic proteins alone, ii, all
identiﬁed proteins except the predicted cytoplasmic pro-
teins, and iii, all identiﬁed proteins except the predicted
cytoplasmic proteins and the proteins of unknown locali-
zation. Unexpectedly, the distinguishing information was
primarily associated with the predicted cytoplasmic pro-
teins Table S6).
Voronoi treemaps can be applied to link quantitative
proteomic data and functional classiﬁcations. Thus, we
used Voronoi treemaps to characterize the extracellular
proteins identiﬁed for the 3 groups of isolates. The bio-
logic functions of the identiﬁed proteins were mainly
related to protein biosynthesis, carbohydrate and carbon
metabolism, oxidative stress, and adhesion (Fig. S1a,
S1b). Of note, adhesion-associated extracellular proteins
were somewhat more pronounced among the HA- than
the CA isolates in the exponential growth phase
(Fig. S1a). Conversely, adhesion-related extracellular
proteins were more prominently present in CA- than in
HA isolates in the stationary growth phase (Fig. S1b).
Despite the fact that there were unique proteins identi-
ﬁed in each of the 3 groups of isolates, no major differen-
ces in the overall functions of the identiﬁed extracellular
proteins were observed.
Figure 6. Northern blotting analysis of selected genes. Arrows mark the positions of 23S- and 16S-rRNA bands on the methylene blue
stained membranes. Sizes of speciﬁc transcripts are indicated on the right side of each display. In case of fabHF 2 bands were detected,
the larger band of »2.2 kb representing a fabHF transcript and the lower band of »1.5 kb only fabF. (a) ebps, (b) fabHF, (c) rpoB, and
(d) psma1–4.
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Differences in staphylococcal survival within
epithelial cells
Since the PCA analysis of exoproteins grouped the stud-
ied S. aureus isolates into 2 distinct clusters, we asked the
question whether these groups might interact differently
with human host cells. A bronchial epithelial cell line
(16HBE14o-) was selected for this purpose, because CA-
MRSA isolates have been implicated in severe respiratory
infections among healthy individuals from the commu-
nity. This fact might indicate a superior ability of this
group of bacteria to interact with airway cells. Further-
more, the 16HBE14o- epithelial cell line forms a conﬂu-
ent layer that allows the monitoring of infecting bacteria
over several days. Thus, in vitro cultured 16HBE14o- epi-
thelial cells were infected with the CADK, HADK and
HANL-DE isolates, and the subsequent binding, internali-
zation and intracellular survival of staphylococci were
assessed through counting by ﬂow cytometry. While the
staphylococcal isolates did not show major differences in
the internalization rate into the epithelial cells, there was
a marked difference in post-internalization growth and
survival. As shown in Fig. 8 and Fig. S2b, 4 CADK isolates
(D15, D32, D37, D69) were able to multiply inside the
epithelial cells during the ﬁrst 2 d post infection, after
which the population size decreased. In contrast, the
HADK isolates did not multiply with the exception of iso-
late D17, which showed a slight increase, comparable to
the CADK isolate D69 (Fig. 8). Of note, the CADK isolates
D29 and D61, which were grouped with the HADK iso-
lates in the exoproteome PCA analysis (Fig. 7), displayed
similar intracellular behavior as the 5 HADK isolates
D03, D22, D30, D53 and D66. Notably, all the 3 HANL-
DE isolates showed a similar intracellular behavior as the
HADK isolates. These ﬁndings imply that the distinction
of the investigated HA and CA isolates based on differ-
ences in their exoproteomes, is reﬂected in their growth
and survival behavior upon internalization of human
bronchial epithelial cells.
Discussion
The serious threat that MRSA represents for hospitalized
patients demands an accurate and reliable method of dis-
tinction between CA- and HA-MRSA isolates for the
Figure 8. Survival of CA and HA isolates internalized by
16HBE14o- bronchial epithelial cells. Averaged survival curves are
shown for the CADK, HADK and HANL-DE isolates, where the CADK
isolates are separated into 2 groups in accordance with their exo-
protein abundance signatures in Fig. 8 (CA-DK-1 includes isolates
D15, D32, D37 and D69; CA-DK-2 includes isolates D29 and D61).
Figure 7. Principal component analysis (PCA) of the normalized spectral counts of identiﬁed extracellular proteins. Two-dimensional
PCA plots are displayed for growth medium samples from the 15 CADK, HADK and HANL-DE isolates in the (a) exponential growth phase
and (b) stationary growth phase.
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purpose of prevention and control of outbreaks. In the
present study, we explored the feasibility of applying a
combined genome and proteomics-based approach to
distinguish MRSA isolates with different epidemiological
behavior. To facilitate the interpretation of the complex
data, we used a set of genetically closely related CA- and
HA-MRSA isolates with the sequence type ST8. Alto-
gether, our ﬁndings revealed several distinguishing fea-
tures between the investigated CA and HA isolates at the
levels of the accessory genome and the exoproteome.
Since exoproteins have major roles in staphylococcal
colonization of the host and virulence, we compared the
exoproteome proﬁles of 3 genetically similar, but epide-
miologically unrelated groups of MRSA isolates, i.e., the
CADK, HADK and HANL-DE isolates. Noticeably, most of
identiﬁed exoproteins was shared by all the 3 groups of
isolates. However, some of the identiﬁed exoproteins
were unique for a particular group of isolates, while the
abundance of several common proteins varied among
the 3 groups of isolates. This probably reﬂects the fact
that the S. aureus exoproteome is heterogeneous due to
this organism’s genomic plasticity.26,27 Nonetheless, the
investigated HANL-DE isolates shared more similarities
with respect to accessory virulence genes and actually
detected exoproteins with the HADK isolates than with
the CADK isolates, even though their core genome was
more closely related to that of the CADK isolates. The lat-
ter ﬁnding is in line with previously reported observa-
tions that genetically closely related S. aureus isolates
may reveal heterogeneous exoproteome proﬁles.38,39
Taken together, our combined observations imply that
both qualitative and quantitative differences in the exo-
proteome proﬁle might serve as markers to discriminate
the 3 groups of S. aureus isolates with different epidemi-
ological backgrounds. Of note, some observed differen-
ces for accessory virulence genes that are apparently
distinctive for the CA and HA isolates at the genome
level, such as the genes for PVL and enterotoxins, were
not reﬂected in the present proteomics analyses, because
the respective proteins were not detected. This lack of
detection may relate to their actual expression levels
under the investigated conditions, or to the fact that the
actual identiﬁcation of proteins by MS depends on vari-
ous factors, including the method of sample preparation,
or the acquisition and analysis of the MS data. Yet, it
should be noted that these proteins were identiﬁed in
some other proteomic studies.40,41
Knowledge of the sub-cellular localization of bacterial
proteins can provide valuable insights into protein func-
tions, especially in relation to colonization of the host,
ﬁtness and virulence.26 In this respect, the attention is
usually focused on actively secreted proteins that are syn-
thesized with N-terminal signal peptides, because these
include the major known virulence factors.26,27 However,
our proteomic analysis revealed only few signiﬁcant dif-
ferences in the detection of actively secreted proteins in
the CA and HA groups that could be related to virulence
(i.e., IsdA and IsdB), adhesion to host tissues (i.e., Ebps,
Vwb), or immune evasion (i.e., SCIN). In addition, some
other known virulence factors, such as CHIPS, the
enterotoxin type D and the enterotoxin type A were
uniquely identiﬁed in the CADK, HADK, and HANLDE iso-
lates, respectively, irrespective of the growth phase.On
the other hand, we observed major differences in the
appearance of predicted cytoplasmic proteins in the exo-
proteomes of the investigated CA and HA isolates, where
a higher number of cytoplasmic proteins was identiﬁed
in the growth medium of the CA group than in the
medium of the 2 HA groups during the exponential
growth phase. Conversely, a higher number of cyto-
plasmic proteins was identiﬁed in the HA group than the
CA group during the stationary growth phase. This dif-
ference can be interpreted in at least 3 ways. Firstly, there
may be a difference in the timing of autolysis of cells36,37
resulting in the early release of cytoplasmic proteins into
the extracellular milieu by cells from the CA group. On
the other hand, it is known that cell wall-associated and
secreted proteases can degrade cytoplasmic proteins
released into the growth medium.36 Hence a second pos-
sible explanation for the observed differences would be
that the HA isolates are more proteolytic in the exponen-
tial growth phase than the CA isolates, leading to the
observed differences due to degradation of liberated
cytoplasmic proteins. In a third possible scenario, ‘cyto-
plasmic’ proteins are actively delivered into the growth
medium via non-classical secretion mechanisms that are
as yet ill-deﬁned.33,34,37 In this case, one would have to
assume that the timing of non-classical secretion differs
for CA and HA isolates. Inspection of the genome
sequences of the investigated MRSA isolates showed that
the genes for known autolysins (atl, isaA, lytM), pro-
teases (aur, sspA, sspB, sspC, spiA, spiB, spiC, spiD, spiE,
spiF and IsaA) and secretion pathways (sec, tat and type
VII secretion) are intact with only few SNPs detectable
in the coding and intergenic regions, as was the case for
major gene regulators. None of the observed SNPs causes
a premature stop of translation or a mutation that is
known to be important for activity (data not shown). Of
note, our comparative genome analysis suggests that the
distinctive features of CA- and HA-MRSA isolates relate
predominantly to the accessory genome, which might
suggest a role of the respective genes at least in the tim-
ing of the extracellular appearance of predicted cyto-
plasmic proteins.
The principal component analysis (PCA) on the exopro-
teome databased on normalized spectral counts grouped
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the 15 investigated S. aureus isolates into 2 distinct groups.
Herein, all the HA isolates formed a distinct cluster,
whereas 4 of the 6 CA isolates formed a separate cluster.
Importantly, the clustering of all HADK and HANL-DE iso-
lates in one group implies that our proteomics approach
identiﬁes a common signature of all investigated HA-
MRSA isolates. Intriguingly, 2 isolates designated as CA
grouped with the HA isolates, suggesting that these 2 “CA
isolates” (D29, D61) may actually be hospital-adapted iso-
lates that could have been propagated in the community.
Consistent with this idea, our Northern blotting analysis
showed that the transcript levels for exoproteins like FabF,
RpoB and PSMa1–4 in the CA isolate D29 resembled more
closely the respective proﬁles in the HA isolates. Yet, this
was not the case for isolate D61, whose fabF and rpoB tran-
script levels matched with those of the CA isolates, while
the psma1–4 transcript level was very low. An alternatively
possibility is that the CA isolates D29 and D61 are genuine
CA isolates, in which case our proteome analyses might
highlight another distinguishing feature of the 2 clusters.
Indeed, the distinction of CA and HA groups based on our
PCA analysis seems to have predictive value for the growth
behavior and survival of S. aureus in non-professional
phagocytic epithelial cells. Clearly, the CA isolates displayed
an increase in net cell number after internalization by epi-
thelial cells compared with the HA isolates, whose bacterial
count did not substantially increase following internaliza-
tion. This ﬁnding would be fully in line with an earlier study
that suggested better survival of CA-MRSA than of HA-
MRSA inside human neutrophils.42 Together, these ﬁnd-
ings imply that the cytoplasmic proteins identiﬁed in the
exoproteome are indicative not only for the epidemiological
behavior, but also could have an impact on the intracellular
behavior of S. aureuswithin epithelial cells inﬂuencing their
survival or replication capabilities. Of course, this does not
exclude the possible involvement of known virulence fac-
tors with a clear role in virulence, such as phenol-soluble
modulins, which were previously implicated in epidemio-
logical behavior and intracellular survival,29,43-45 or the leu-
kocidins PVL or LukAB/ED.46
In recent years, increasing evidence has been obtained
that particular cytoplasmic proteins may have different
functions at intracellular and extracellular locations.47,48
Such proteins are often regarded as ‘moonlighting’ pro-
teins. Of note, the cytoplasmic proteins which we could
consider here as potential moonlighting proteins are
mostly proteins that are constitutively expressed at
relatively high levels, and that have previously identi-
ﬁed roles in processes such as sugar metabolism, adher-
ence to host tissues, pathogenesis, and/or immune
evasion.49-52 Of note, several of these potentially moon-
lighting proteins do not only occur in prokaryotes but
also in eukaryotes, which could be suggestive of
molecular mimicry where pathogens disguise them-
selves with a corona of factors that the human immune
system does not recognize as non-self.50,53,54 Alto-
gether, the possible roles of moonlighting cytoplasmic
proteins in the different epidemiology and intracellular
survival of CA and HA USA300 isolates as highlighted
in our present study would be fully in line with recent
studies where it was proposed that such proteins con-
tribute to staphylococcal virulence.33,35,55,56
We conclude that our present proteomics approach to
identify exoproteome signatures, and the results obtained
with this approach, open up novel avenues to study and
predict the epidemiological behavior of clinical MRSA
isolates. Clearly, our study is built on genetically closely
related MRSA isolates with distinct epidemiological
behavior. It will be an important challenge for future
research to assess whether a similar distinction can be
achieved when this approach is applied to genetically dis-
tantly related MRSA isolates with different epidemiologi-
cal behavior in hospitals and the community.
Materials and methods
Bacterial isolates
Relevant properties of the 15 MRSA isolates used for
exoproteome analyses are listed in Table S7. 12 isolates
with the PFGE proﬁle USA300 were collected by the
Statens Serum Institut (Copenhagen, Denmark) in the
period between 1999 and 2006.21 These 12 isolates
included 6 CA-MRSA isolates with spa type t008
(referred to as CADK), and 6 HA-MRSA isolates with spa
type t024 (referred to as HADK).18,21 The remaining 3
HA-MRSA isolates with spa types t008 or t024 (referred
to as HANL-DE isolates) were collected in the period
between 1996 to 2010 in hospitals located within the
Dutch-German border region (EUREGIO).19
Whole genome sequencing of isolates and analysis
Whole genome sequencing of the investigated S. aureus
isolates was performed on an Illumina MiSeq instrument
and the Nextera XT, 2 £ 250bp kit using the manufac-
turer’s standard protocols (Illumina, Inc., USA). DNA
for the sequencing was extracted using the DNeasy Blood
and Tissue kit (Qiagen, Valencia, CA, USA). The WGS
data sets generated and/or analyzed in the current study
are available in the European Nucleotide Archive (ENA)
repository under accession number ERP018940 (http://
www.ebi.ac.uk/ena/data/view/PRJEB17079). Reads from
the isolates were assembled using SPAdes,57 annotated
using PROKKA,58 and the core and pan-genome of the
isolates was estimated using ROARY.59 The alignment of
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the core genome from ROARY was used as input to cre-
ate a phylogenetic tree using RAxML60 with 100 boot-
strap supports. The phylogenetic tree and accessory
genome heatmap were visualized using ggtree. Speciﬁ-
cally, the phylogenetic tree was based on the variable
positions in the core genome of the 15 isolates (2,334
genes). The accessory genome was deﬁned as genes pres-
ent in at most 70% of the isolates resulting in 992 acces-
sory genes. Virulence genes were identiﬁed using
VirulenceFinder.61 The analysis of potential antimicro-
bial resistance genes was performed with the web-based
ResFinder tool.62
Bacterial cultivation for proteome sampling
Bacteria were grown overnight (14–16 h) at 37C in
25 mL Trypton Soy Broth (TSB) under vigorous shaking
(115 rpm). The cultures were then diluted into 25 mL
pre-warmed RPMI 1640 medium supplemented with
2 mM glutamine (GE Healthcare/PAA, Little Chalfont,
United Kingdom) to an OD600 of 0.05 and cultivation
was continued under the same conditions. Exponentially
growing cells with an OD600 of »0.5 were re-diluted into
120 mL fresh, pre-warmed RPMI medium to a ﬁnal
OD600 of 0.05. The cultivation was continued until the
cultures had reached 90 min within the stationary
growth phase. Within this period, 2 time points were
selected for sample collection. The ﬁrst one was set at
OD600 of »0.5, corresponding to the exponential growth
phase, and the second one was set at »OD600 of 1.3, cor-
responding to approx. 90 min after entry into the sta-
tionary phase. At these 2 time points, 1.5 ml culture
aliquots were collected. In brief, the collected aliquots
were centrifuged for 10 min at 4C and 8000 £ g with
the subsequent application of a 0.22 mM ﬁlter step (GE
Healthcare Systems, Little Chalfont, United Kingdom) to
remove the remaining bacterial cells. The extracellular
proteins in the supernatant were precipitated with 10%
w/v TCA on ice at 4C overnight. Finally, the precipitates
were collected by centrifugation for 20 min at 4C and
8000 £ g, washed with ice-cold acetone, and dried at
room temperature. The dried protein pellets were stored
at ¡20C until further use. For each isolate 2 biologic
replicates were analyzed, which adds up to 24 exponen-
tial phase and 24 stationary phase samples for the CADK
and HADK strains, respectively, and to 6 exponential
phase and 6 stationary phase samples for the HANL-DE
strains.
Sample preparation for proteome analysis
Dried protein samples were processed as described previ-
ously.54 Brieﬂy, protein pellets were dissolved in 50 mM
ammonium bicarbonate buffer (Fluka, Buchs, Switzer-
land), reduced with 10 mM dithiothreitol (DuchefaBio-
chemie, Haarlem, the Netherlands) for 30 min, and
alkylated with 10 mM iodoacetamide (Sigma-Aldrich, St.
Louis, USA) for 30 min in the dark. To digest complex
protein samples, 80 ng trypsin (Promega, Madison,
USA) was added and the samples were incubated
overnight at 37C under static conditions. To stop the
digestion, the samples were acidiﬁed with a ﬁnal concen-
tration of 0.1% triﬂuoroacetic acid (TFA, Sigma-Aldrich,
St. Louis, USA) and subsequently puriﬁed using ZipTips
(Millipore, Billerica, USA). For this purpose, the tips
were stepwise equilibrated with 30 mL acetonitrile (ACN,
Fluka, Buchs, Switzerland), 30 mL 80% ACN/0.1% TFA,
50% ACN/0.1% TFA, 30 mL 30% ACN/0.1% TFA and
ﬁnally 30 mL 0.1% TFA. Peptides were bound to ZipTips
by pipetting 10 times 10 mL of the sample. Impurities
were removed by washing with 50 mL 0.1% TFA and
ﬁnally peptides were eluted with 20 mL 50% ACN/0.1%
TFA and 20 mL 80% ACN/0.1% TFA. The ﬁnal eluates
were concentrated using a vacuum centrifuge (Eppen-
dorf, Hamburg, Germany) and stored at 4C until fur-
ther use.
Mass spectrometry
Tryptic peptides were separated by reversed phase liquid
chromatography (LC) coupled online to electrospray
ionization mass spectrometry (ESI-MS) using an LTQ
Orbitrap as described by Stobernack et al.63 Database
searching was done with Sorcerer-SEQUEST 4 (Sage-N
Research, Milpitas, USA). After extraction from the raw
ﬁles, .dta ﬁles were searched with Sequest against a tar-
get-decoy database with a set of common laboratory con-
taminants. The databases for the respective peptide/
protein search were created from the genome sequences
of the 15 investigated MRSA isolates. The RAST annota-
tion ﬁle of these 15 MRSA isolates was used to create a
non-redundant database comprising protein sequences
of all isolates. Protein sequences that differed in only one
amino acid were included in this database. Finally, vali-
dation of MS/MS-based peptide and protein identiﬁca-
tions was performed with Scaffold v4.3.4 (Proteome
Software, Portland, USA). Peptide identiﬁcations were
accepted if they exceeded speciﬁc database search engine
thresholds. SEQUEST identiﬁcations required at least
deltaCn scores of greater than 0.1 and XCorr scores of
greater than 2.2, 3.3 and 3.75 for doubly, triply and qua-
druply charged peptides, respectively. With these ﬁlter
parameters, no false-positive hits were obtained, which
was veriﬁed by a search against a concatenated target-
pseudo reversed decoy database. Normalized spectral
counts were obtained from the Scaffold ﬁle by
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considering a 99% protein threshold, and a minimum of
2 peptides for each protein. The normalized spectral
count data were exported from Scaffold and curated in
Microsoft Excel before further analysis. The ﬁlteredMS data
associatedwith thismanuscript can be downloaded from the
PRIDE partner repository of the ProteomeXchange Consor-
tium using the following link: http://www.ebi.ac.uk/pride/
archive/login.
Prediction of protein localization, biologic processes
and molecular functions
Prediction of the subcellular localization of proteins that
were identiﬁed by LC-MS/MS was performed using dif-
ferent bioinformatics tools. Since individual bioinformat-
ics tools are not able to speciﬁcally predict all possible
localization sites of bacterial proteins,64 we used 8 differ-








HMM),71 and CDD-batch search (https://www.ncbi.
nlm.nih.gov/Structure/bwrpsb/bwrpsb.cgi).72 The
settings used for of each program are speciﬁed in Table
S8. A detailed description of output parameters, scores
and thresholds for each tag is presented in Table S9.
Voronoi treemaps to link quantitative proteomic data
and functional classiﬁcations were created using the
Paver software (DECODON GmbH, Greifswald, Ger-
many) with the latest functional categorization of SEED
database of S. aureus USA300_FPR3757.73
RNA isolation
Bacterial isolates were grown under the same condition
as for the proteomics sample collection. 25 ml culture ali-
quots were collected for RNA isolation 90 min after entry
into the stationary growth phase, corresponding to an
OD600 of approx. 1.3. RNA was isolated from bacteria as
described previously.74 Brieﬂy, 1/2 volume of frozen kill-
ing buffer (20 mM Tris/HCl [pH 7.5], 5 mM MgCl2,
20mM NaN3) was added to the bacterial culture, and
bacterial cells were collected by centrifugation for 3
minutes, 8000 rpm at 4C. The supernatant was dis-
carded, and pellets were frozen in liquid nitrogen and
stored at ¡80C until further processing. Cell pellets
were re-suspended in ice-cold killing buffer and trans-
ferred into Teﬂon vessels ﬁlled with liquid N2 for disrup-
tion. Cells were then mechanically disrupted with a
Mikro-Dismembrator S (Sartorius) for 2 min, 2600 rpm.
The resulting powder was re-suspended in lysis solution
that was pre-warmed at 50C (4 M guanidine thiocya-
nate, 25 mM sodium acetate [pH 5.2], 0.5% N-laurylsar-
cosinate 40 [wt/vol]) by repeated up- and down-
pipetting. Then, lysates were transferred into pre-cooled
micro-centrifuge tubes, and frozen at ¡80C.
Total RNA was isolated by phenol-chloroform extrac-
tion as described previously.74 Samples were processed
twice with an equal volume of acid phenol solution
(Sigma-Aldrich, Zwijndrecht, the Netherlands), and
mixed thoroughly on an Eppendorf tube shaker until
completely thawed. The resulting suspension was then
centrifuged for 5 min, 12000 rpm, and the supernatant
was transferred into a fresh microcentrifuge tube. Next,
samples were processed once with one volume of Chlo-
roform/isoamyl alcohol, mixed well, and centrifuged for
5 min, 12000 rpm. RNA was precipitated from the super-
natant by the addition of 1/10 volume of 3 M Na-Ace-
tate, pH 5.2, and 0.8 ml of isopropanol. The precipitated
RNA was washed once with 70% RNase-free ethanol,
and dissolved in RNase-free water.
Northern blot analysis
Northern blot analysis was performed as described previ-
ously.75 Speciﬁc biotin-labeled RNA probes were gener-
ated by in vitro synthesis using a T7 RNA polymerase
and Bio-16-UTP (Life Technologies). 3–10 mg of total
RNA per lane was separated on 1.2% denaturing agarose
gels. Gene-speciﬁc transcripts were detected with the aid
of biotin-labeled anti-sense RNA-probes. Fluorescent
detection of the biotin- labeled probes was performed
using IRDye 800CW Streptavidin (LI-COR Biosciences
- GmbH) and the Odyssey Clx Imaging System (LI-COR
Biosciences - GmbH) according to the instructions of the
manufacturer. Primer sequences are listed in Table S10.
Survival of bacteria upon epithelial cell infection
Cell lines and culture conditions
The human bronchial epithelial cell line 16HBE14o- was
used to investigate the survival of MRSA isolates upon
internalization. The epithelial cells were cultured in
eukaryotic minimal essential medium (eMEM; 1x MEM
without arginine and lysine; Costumer formulation, Pro-
moCell GmbH, Heidelberg, Germany) supplemented
with 10% (v/v) fetal calf serum (FCS; Biochrom AG, Ber-
lin, Germany), 2% (v/v) L-glutamine 200 mM (PAN-
Biotech GmbH, Aidenbach, Germany) and 1% (v/v)
non-essential amino acids 100x (PAN-Biotech GmbH).
The cells were seeded at a density of 1 £ 105 cells/cm2 in
CellStar 12-well plates (Greiner Bio-One,
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Frickenhausen, Germany) and cultured for 3 d at 37C,
5% CO2 in a humidiﬁed atmosphere after which they
were ready for infection experiments.
Bacterial culture conditions
The bacteria were cultured in prokaryotic minimal essential
medium (pMEM; 1x MEM without sodium bicarbonate;
Invitrogen, Karlsruhe, Germany) supplemented with 1x
non-essential amino acids (PAN-Biotech GmbH), 4 mM
L-glutamine (PAN-Biotech GmbH), 10 mMHEPES (PAN-
Biotech GmbH), 2 mM L-alanine, 2 mM L-leucine, 2 mM
L-isoleucine, 2 mM L-valine, 2 mM L-aspartate, 2 mM
L-glutamate, 2 mM L-serine, 2 mM L-threonine,
2 mML-cysteine, 2 mML-proline, 2 mML-histidine, 2 mM
L-phenyl alanine and 2 mM L-tryptophan (Sigma-Aldrich,
Munich, Germany), adjusted to pH 7.4 and sterilized
through ﬁltration. Notably, for the overnight pre-culture
0.01% of yeast extract was added.
Internalization procedure
The internalization of MRSA into epithelial cells was
performed as described previously by Pf€ortner et al.76
Brieﬂy, bacterial cultures were inoculated from exponen-
tially growing overnight cultures, starting at an inocula-
tion OD600 of 0.05 and permitting growth until the
mid-exponential phase at 37C, 150 rpm in a shaking
water bath. The bacterial numbers were determined by
ﬂow cytometry with a Guava easyCyteTM ﬂow cytometer
(MilliporePrior Billerica, MA, USA). Prior to infection,
the numbers of epithelial cells were assessed by detaching
them from the plates with trypsin-EDTA 0.25% (Thermo
Fisher Scientiﬁc, Waltham, USA), mixing with Trypan
blue dye, and counting with a Countess cell counter
(Invitrogen, Karlsruhe, Germany). To infect epithelial
cells with MRSA at a multiplicity of infection (MOI) of
1:25, the host cell medium was exchanged with the infec-
tion mix (MRSA diluted on eMEM, buffered with 2.9 ml
sodium hydrogen carbonate [7.5%] per ml of bacterial
culture added) and incubated for one hour at 37C, 5%
CO2 in an incubator. Afterwards, the cell culture
medium was exchanged with fresh eMEM containing 10
mg/ml lysostaphin, and this medium was exchanged
every 2 d for long-term experiments.
Sampling of the 16HBE14o- cells was performed by
detaching of the cells from the plate with trypsin-EDTA
0.25%, and the collection of internalized bacteria was per-
formed through incubation of the plate with 0.05% SDS for
5min. Quantiﬁcation of the intracellular MRSA isolates was
performed by ﬂow cytometry with a GUAVAeasyCyte
(Merck Millipore, Darmstadt, Germany). To this end, the
bacteria were stained with 0.2mg/ml Vancomycin BODIPY
FL (Thermo Fisher Scientiﬁc,Waltham, USA), and detected
using a 488 nm laser for excitation as described.77 The
intracellular survival of each isolate was analyzed in inde-
pendent duplicate experiments.
Graphical and statistical analyses
Volcano plot analyses were performed using GraphPad
Prism version 6. Statistical analyses were performed
using the Wilcoxon signed-rank test. A P-value of less
than or equal to 0.05 was considered statistically signiﬁ-
cant. Principal component analysis (PCA) was per-
formed using the Statistical Package for Social Science
(SPSS) version 22. The component loading of the extra-
cellular proteins from the 15 CADK, HADK and HANL-DE
isolates was calculated both for growth medium fractions
of cells in the exponential and stationary growth phases
based on normalized spectral count. The Venn diagram
was constructed using Venny version (http://bioinfogp.
cnb.csic.es/tools/venny/).
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